Newsroom
Sorted by: Latest
-
Advanced Semiconductor Packaging Market Research Report 2025-2035: Technological Innovations are Reshaping the Semiconductor Landscape Beyond Traditional Moore's Law Scaling - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "The Global Advanced Semiconductor Packaging Market 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Global Advanced Semiconductor Packaging Market 2025-2035 provides a comprehensive analysis of the rapidly evolving advanced semiconductor packaging industry, examining how technological innovations are reshaping the semiconductor landscape beyond traditional Moore's Law scaling. The report provides essential strategic intelligence for semico...
-
Wallbox and PowerGo Announce Collaboration to Deploy EV Charging Solutions Across Hotels in the Netherlands
BARCELONA, Spain--(BUSINESS WIRE)--Wallbox (NYSE: WBX), a leading provider of electric vehicle (EV) charging and energy management solutions, has announced a collaboration with charge point operator PowerGo to accelerate the deployment of AC and DC charging infrastructure across Essendi hotels in the Netherlands. This collaboration brings together Wallbox’s advanced charging technology and PowerGo’s renewable energy-powered infrastructure to support the country’s growing demand for sustainable...
-
Chiesi Global Rare Diseases vergibt Forschungsstipendien zur Förderung von Innovationen bei lysosomalen Erkrankungen
PARMA, Italien--(BUSINESS WIRE)--Chiesi Global Rare Diseases, ein Geschäftsbereich der Chiesi Group, der gegründet wurde, um innovative Lösungen für Menschen mit seltenen Krankheiten anzubieten, gab heute die Preisträger seines Forschungsstipendienprogramms „Find For Rare” bekannt. Die unabhängig bewertete, von Experten geleitete Forschungsstipendieninitiative zielt darauf ab, die Patientenversorgung und -behandlung zu verbessern, indem innovative Forschung zu drei lysosomalen Erkrankungen ausg...
-
Memory and Storage Technology Research Report 2025: AI-Driven Demand Propels Global Memory and Storage Market Toward $400 Billion by 2036 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "The Global Memory and Storage Technology Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Memory and Storage Technology Market 2026-2036 provides insights into the rapidly evolving memory and storage landscape, delivering critical analysis for technology leaders, investors, and strategic decision-makers navigating the industry's transformation through 2036. The global memory and storage technology market is poised for signifi...
-
Resumen: Brenus Pharma e InSphero han desarrollado esferoides tumorales en 3D que imitan las condiciones in vivo del cáncer colorrectal humano y confirman la eficacia de STC-1010
LISBOA, Portugal--(BUSINESS WIRE)--Brenus Pharma, empresa biotecnológica francesa dedicada al desarrollo de inmunoterapias innovadores de nueva generación, e InSphero, líder suizo en tecnologías de ensayos basadas en células 3D, presentaron datos prometedores en el congreso anual de la Asociación Europea para la Investigación del Cáncer 2025. Estos datos corroboran el uso de esferoides tumorales 3D para evaluar la eficacia de STC-1010, el principal candidato de Brenus contra el cáncer colorrect...
-
Neutral-Atom Quantum Computing Global Market Report 2026-2036 with Profiles of 35+ Key Players Including System Manufacturers, Component Suppliers, Software Developers, and Platform Providers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "The Global Neutral-Atom Quantum Computing Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Market for Neutral Atom Quantum Computers 2026-2036 provides an exhaustive analysis of the rapidly expanding neutral atom quantum computing sector, delivering critical insights into market dynamics, technology evolution, competitive landscapes, and ten-year growth projections. As neutral atom systems emerge as formidable challengers to...
-
Brenus Pharma et InSphero ont mis au point des sphéroïdes tumorales 3D imitant les conditions in vivo de cancer colorectal humain et confirmant l'efficacité du STC-1010
LISBONNE, Portugal--(BUSINESS WIRE)--Brenus Pharma, la biotech française développant des immunothérapies de nouvelle génération, et InSphero, le chef de file suisse des technologies d'analyse 3D à base de cellules, ont présenté des données prometteuses lors du congrès annuel 2025 de l'Association européenne pour la recherche sur le cancer. Ces données confirment l’utilisation de sphéroïdes tumoraux 3D pour le test de puissance du STC-1010, candidat principal de Brenus dans le traitement du canc...
-
Brenus Pharma und InSphero haben 3D-Tumorsphäroide entwickelt, die in vivo menschliche Darmkrebserkrankungen nachahmen und die Wirksamkeit von STC-1010 bestätigen
LISSABON, Portugal--(BUSINESS WIRE)--Brenus Pharma, ein französisches Biotechunternehmen, das First-in-Class-Immuntherapien der nächsten Generation entwickelt, und InSphero, ein Schweizer Marktführer bei 3D-Zell-Assay-Technologien, haben auf dem Jahreskongress 2025 der European Association for Cancer Research vielversprechende Daten präsentiert. Diese Daten bestätigen den Nutzen von 3D-Tumorsphäroiden bei der Wirksamkeitsprüfung von STC-1010, dem führenden Wirkstoffkandidaten von Brenus für Dar...
-
Riassunto: Brenus Pharma e InSphero hanno sviluppato sferoidi tumorali tridimensionali che imitano in vivo le condizioni del tumore del colon-retto nell'uomo e confermano l'efficacia di STC-1010
LISBONA, Portogallo--(BUSINESS WIRE)--Brenus Pharma, azienda biotecnologica francese che sviluppa immunoterapie di nuova generazione prime nel settore, e InSphero, un leader svizzero nelle tecnologie di saggi a base cellulare tridimensionali, ha presentato dati promettenti al congresso annuale 2025 della European Association for Cancer Research. Questi dati confermano l'uso di sferoidi tumorali tridimensionali per testare l'efficacia di STC-1010, il principale candidato farmaco per il tumore de...
-
Montanaro Asset Management UK Regulatory Announcement: Form 8.3 - ME Group International Plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Montanaro Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mus...